(R)-(+)-Propranolol hydrochloride
SIGMA/P0689 - ≥98% (TLC)
Synonym: Propranolol HCl; (R)
CAS Number: 13071-11-9
Empirical Formula (Hill Notation): C16H21NO2 · HCl
Molecular Weight: 295.80
EC Number: 235-961-7
MDL Number: MFCD00064546
Linear Formula: C10H7OCH2CH(OH)CH2NHCH(CH3)2·HCl
Product Type: Chemical
| assay | ≥98% (TLC) |
| InChI | 1S/C16H21NO2.ClH/c1-12(2) |
| InChI key | ZMRUPTIKESYGQW-PFEQFJNWSA |
| mp | 196-198 °C (lit.) |
| originator | AstraZeneca |
| Quality Level | 200 ![]() |
| SMILES string | Cl.CC(C)NC[C@@H](O)COc1cc |
| solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclode |
| DMSO: <14.5 mg/mL | |
| ethanol: 10 mg/mL | |
| H2O: 50 mg/mL | |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | Less active enantiomer of propranolol. |
| Features and Benefits: | This compound was developed by AstraZeneca . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | With heat. Aqueous solutions are most stable at pH 3.0 and decompose rapidly at basic pH. Decomposition is accompanied by discoloration of the solution. |
| Packaging: | 100, 500 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264 - P270 - P301 + P312 - P501 |
| Hazard Codes | Xn |
| Risk Statements | 22 |
| Safety Statements | 22-24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (TLC) |
| mp | 196-198 °C (lit.) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |


